CHR Metz Thionville
Metz, Moselle, 57085, France
NCT Number: NCT04886440
Salivary disorders are common reason for ENT specialist consultation. Sialolithiasis are the most frequent salivary obstruction disease and are characterized by the development of calcified structures in the salivary gland, especially in the submandibular gland.
The management of salivary obstruction has changed over the past 30 years. Sialendoscopy is considered as a minimally invasive procedure that allows endoscopic visualization of the salivary ductal system and is increasingly used in both diagnosis and treatment. Moreover, many studies have shown the effectiveness of this procedure.
Classification of lithiasis has been set up in 2008 to standardize the nomenclature and was used for patient care since 2009. The main objective of this study is to evaluate the relevance of the lithiasis's classification to predict the efficacy of sialendoscopy in treatment of sialolithiases.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Metz, Moselle, 57085, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Month 6
Absence or presence of symptoms associated to lithiasis
Time frame: Day 1
number of clinical signs of the clinical suspicion
Time frame: Day 1
number of intraoperative complications
Time frame: Day 1
Number of post-operative complications
Centre Hospitalier Régional Metz-Thionville
Other
Predictive Value of the Sialendoscopy in Treatment of Submandibular Gland Sialolithiasis: a Retrospective Study
Acronym: SIAGLA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04103762
Biliary Tract Diseases, Cholangiopathy
Amiens, France
View Trial DetailsNCT05937256
Lithiasis, Neurologic Manifestations
Qina, Qena Governorate, Egypt
View Trial DetailsNCT05525130
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Granada, Spain
View Trial DetailsNCT03483532
Lithiasis, Pathologic Processes
Manacor, Balearic Islands, Spain
View Trial Details